Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2022
Alnylam sues Moderna and Pfizer over lipid patent
Alnylam filed lawsuits against Moderna and Pfizer in federal court in Delaware, alleging that their COVID-19 vaccines infringe its biodegradable-lipids patent. Alnylam said it was seeking monetary relief and did not want to impede vaccine sales, production or distribution. Moderna denied the allegation; Pfizer had not commented to the outlet.
2021
FDA authorizes Pfizer-BioNTech COVID-19 vaccine booster for certain populations
The FDA amended the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to allow a single booster dose, at least six months after completion of the primary series, for certain populations.
2021
FDA authorizes limited Pfizer-BioNTech booster shots
The FDA approved Pfizer/BioNTech COVID-19 booster shots for certain eligible populations, including people aged 65 and older at least six months after their second dose.
2021
FDA expands Pfizer-BioNTech vaccine authorization to adolescents
The FDA expanded the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents aged 12 through 15.
2020
Singapore signs advance-purchase agreements with three vaccine makers
Singapore signed advance-purchase agreements with Moderna, Pfizer-BioNTech and Sinovac for COVID-19 vaccines. The report said the first Pfizer vaccine batch was due to arrive by the end of December, with the other companies' vaccines expected to arrive the following year.